Experimental new rheumatoid arthritis drug passes final phase of human trials

A novel experimental drug is showing promising results from its final phase of human clinical trials. Part of a new class of drugs called JAK-inhibitors, this therapy targets rheumatoid arthritis sufferers and is hoped to be approved for use by the FDA within the next 12 months.

.. Continue Reading Experimental new rheumatoid arthritis drug passes final phase of human trials

Category: Medical

Tags:

• Arthritis
• Drugs
• FDA

from New Atlas (Gizmag) https://ift.tt/2Y2pd3A